title: Genetic testing for warfarin dosing? Not yet ready for prime time.
authors.forename: Henry I
authors.initials: HI
authors.lastname: Bussey
authors.forename: Ann K
authors.initials: AK
authors.lastname: Wittkowsky
authors.forename: Elaine M
authors.initials: EM
authors.lastname: Hylek
authors.forename: Marie B
authors.initials: MB
authors.lastname: Walker
mesh_terms: D000465:Algorithms; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D065729:Cytochrome P-450 CYP2C9; D054796:Drug Dosage Calculations; D005838:Genotype; D006801:Humans; D019934:International Normalized Ratio; D006899:Mixed Function Oxygenases / Q000235:genetics*; D010597:Pharmacogenetics; D064417:Vitamin K Epoxide Reductases; D014859:Warfarin / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D000925:Anticoagulants; D014859:Warfarin; D006899:Mixed Function Oxygenases; C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases; D064417:Vitamin K Epoxide Reductases